SLC25A13 gene analysis in neonates with intrahepatic cholestasis caused by citrin deficiency

WEN Peng-Qiang; WANG Guo-Bing; CHEN Zhan-Ling; CUI Dong; YUAN Quan; SONG Ping; CHEN Shu-Li; LIAO Jian-Xiang; LI Cheng-Rong

PDF(1348 KB)

Chinese Journal of Contemporary Pediatrics ›› 2011, Vol. 13 ›› Issue (4) : 303-308.

CLINICAL RESEARCH

SLC25A13 gene analysis in neonates with intrahepatic cholestasis caused by citrin deficiency

WEN Peng-Qiang, WANG Guo-Bing, CHEN Zhan-Ling, CUI Dong, YUAN Quan, SONG Ping, CHEN Shu-Li, LIAO Jian-Xiang, LI Cheng-Rong

Author information +

History +

Abstract

OBJECTIVE: Neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD) which resulted from mutation in SLC25A13 gene can present transient intrahepatic cholestasis, low birth weight, growth retardation, hypoproteinemia and so on. This study aimed to identify the mutation type of NICCD patients by DNA sequencing. METHODS: Twenty children diagnosed as NICCD were consented to enroll in this study. PCR assays were performed to amplify the eighteen exons and its flanking sequences of SLC25A13 gene, which were defined as the upstream and downstream 50 bp from starting and ending site of the exons. Then the PCR products were purified and followed by automated DNA sequencing. The IVS16ins3kb mutation was detected by nested PCR and RT-PCR. RESULTS: Seven genetic variations of SLC25A13, termed as 851del4, 1638ins23, IVS16ins3kb, IVS6+5G>A, c.775C>T (p.Q259X), c.1505C>T (p.P502L) and c.1311C>T (p.C437C), were identified in the subjects, of which c.775C>T (p.Q259X), c.1505C>T (p.P502L) and c.1311C>T (p.C437C) were reported for the first time in NICCD patients. And a compound mutation of ［1638ins23+IVS16ins3kb］ was also identified. In 20 patients with NICCD, 6 patients were 851del4 homozygotes, 7 patients were compound heterozygotes, and 7 patients were heterozygotes of single mutation. 851del4 was the major mutation type (64%), followed by 1638ins23 (15%), IVS16ins3kb (12%) and IVS6+5G>A (6%). CONCLUSIONS: 851del4 is the major mutation type in Chinese patients with NICCD.

Key words

Citrin deficiency / Neonatal intrahepatic cholestasis / SLC25A13 gene / Jaundice / Neonate

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

WEN Peng-Qiang, WANG Guo-Bing, CHEN Zhan-Ling, CUI Dong, YUAN Quan, SONG Ping, CHEN Shu-Li, LIAO Jian-Xiang, LI Cheng-Rong. SLC25A13 gene analysis in neonates with intrahepatic cholestasis caused by citrin deficiency[J]. Chinese Journal of Contemporary Pediatrics. 2011, 13(4): 303-308

References

［1］Lu YB, Kobayashi K, Ushikai M, Tabata A, Iijima M, Li MX, et al. Frequency and distribution in East Asia of 12 mutations identified in the SLC25A13 gene of Japanese patients with citrin deficiency［J］. J Hum Genet, 2005, 50(7): 338-346.

［2］宋元宗，郝虎，牛饲美晴，柳国胜，肖昕，佐伯武顿，等. 疑难病研究—citrin缺陷导致的新生儿肝内胆汁淤积症［J］. 中国当代儿科杂志，2006，8(2): 125-128.

［3］Yasuda T, Yamaguchi N, Kobayashi K, Nishi I, Horinouchi H, Jalil MA, et al. Identification of two novel mutations in the SLC25A13 gene and detection of seven mutations in 102 patients with adult-onset type II citrullinemia［J］. Hum Genet, 2000, 107(6): 537-545.

［4］Ohura T, Kobayashi K, Tazawa Y, Abukawa D, Sakamoto O, Tsuchiya S, et al. Clinical pictures of 75 patients with neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD)［J］. J Inherit Metab Dis, 2007, 30(2): 139-144.

［5］Tabata A, Sheng JS, Ushikai M, Song YZ, Gao HZ, Lu YB, et al. Identification of 13 novel mutations including a retrotransposal insertion in SLC25A13 gene and frequency of 30 mutations found in patients with citrin deficiency［J］. J Hum Genet, 2008, 53(6): 534-545.

［6］Sinasac DS, Crackower MA, Lee JR, Kobayashi K, Saheki T, Scherer SW, et al. Genomic structure of the adult-onset type II citrullinemia gene, SLC25A13, and cloning and expression of its mouse homologue［J］. Genomics, 1999, 62(2): 289-292.

［7］Kobayashi K, Sinasac DS, Iijima M, Boright AP, Begum L, Lee JR, et al. The gene mutated in adult-onset type II citrullinaemia encodes a putative mitochondrial carrier protein［J］. Nat Genet, 1999, 22(2): 159-163.

［8］Ohura T, Kobayashi K, Tazawa Y, Nishi I, Abukawa D, Sakamoto O, et al. Neonatal presentation of adult-onset type II citrullinemia［J］. Hum Genet, 2001, 108(2): 87-90.

［9］Tazawa Y, Kobayashi K, Ohura T, Abukawa D, Nishinomiya F, Hosoda Y, et al. Infantile cholestatic jaundice associated with adult-onset type II citrullinemia［J］. J Pediatr, 2001, 138(5): 735-740.

［10］Tomomasa T, Kobayashi K, Kaneko H, Shimura H, Fukusato T, Tabata M, et al. Possible clinical and histologic manifestations of adult-onset type II citrullinemia in early infancy［J］. J Pediatr, 2001, 138(5): 741-743.

［11］Dimmock D, Maranda B, Dionisi-Vici C, Wang J, Kleppe S, Fiermonte G, et al. Citrin deficiency, a perplexing global disorder［J］. Mol Genet Metab, 2009, 96(1): 44-49.

［12］Kobayashi K, Ushikai M, Song YZ. Overview of citrin deficiency: SLC25A13 mutations and the frequency［J］. 实用儿科临床杂志, 2008, 23(20): 1553-1557.

［13］宋元宗，盛建胜，牛飼美晴，胡務亮，张春花，小林圭子. Citrin 缺陷导致的新生儿肝内胆汁淤积症 SLC25A13 基因三个新突变的识别及诊断［J］. 中华儿科杂志，2008，46 (64)：411-415.

［14］刑雅智，邱文娟，叶军，韩连书，许姗姗，张惠文，等. Citrin 缺陷导致的新生儿肝内胆汁淤积症临床和SLC25A13基因突变的研究［J］. 中华医学遗传学杂志, 2010，27(2)：180-185.

［15］Song YZ, Li BX, Chen FP, Liu SR, Sheng JS, Ushikai M, et al. Neonatal intrahepatic cholestasis caused by citrin deficiency: clinical and laboratory investigation of 13 subjects in mainland of China［J］. Dig Liver Dis, 2009, 41(9): 683-689.

［16］Ben-Shalom E, Kobayashi K, Shaag A, Yasuda T, Gao HZ, Saheki T, et al. Infantile citrullinemia caused by citrin deficiency with increased dibasic amino acids［J］. Mol Genet Metab, 2002, 77(3): 202-208.

［17］Wong LJ, Dimmock D, Geraghty MT, Quan R, Lichter-Konecki U, Wang J, et al. Utility of oligonucleotide array-based comparative genomic hybridization for detection of target gene deletions［J］. Clin Chem, 2008, 54(7): 1141-1148.

［18］张绍仁，王晓红，朱启镕，刘丽艳，王建设. 婴儿肝内胆汁淤积症 SLC25A13 基因突变分析［J］. 中国循证儿科杂志，2008，3(3)：190-195.

［19］卢致琨，刘丽，李秀珍，程静，梅慧芬. 疑似新生儿肝内胆汁淤积症 SLC25A13 基因突变检测分析［J］. 中国实用儿科杂志，2008，23(9): 675-678.